RecruitingNCT03742011

Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study

Health of Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study


Sponsor

Guangzhou Women and Children's Medical Center

Enrollment

2,000 participants

Start Date

Feb 1, 2012

Study Type

OBSERVATIONAL

Conditions

Summary

The Offspring Born to Mothers with Polycystic Ovary Syndrome in Guangzhou Cohort study (PCOS-BIG) was established to investigate the short- and long-term effects of intrauterine exposure to maternal PCOS on the health of offspring in Guangzhou, China. Data are collected regarding maternal PCOS subtypes, nursing, diet and education as well as health outcomes in their later life. Biological samples including blood and tissue samples are also collected from participants.


Eligibility

Max Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with endocrine disorder, epigenetics, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Guangzhou Women and Children's Medical Center, China

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03742011


Related Trials